Header Logo

Godspower

Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Manne-Goehler J, Fabian J, Sokhela S, Akpomiemie G, Rahim N, Lalla-Edward ST, Brennan AT, Siedner MJ, Hill A, Venter WDF. Blood pressure increases are associated with weight gain and not antiretroviral regimen or kidney function: a secondary analysis from the ADVANCE trial in South Africa. J Int AIDS Soc. 2024 Jul; 27(7):e26268. PMID: 38978403; PMCID: PMC11231445.
      Citations:    Fields:    Translation:HumansCTClinical Trials
    2. Mpofu R, Kawuma AN, Wasmann RE, Akpomiemie G, Chandiwana N, Sokhela SM, Moorhouse M, Venter WDF, Denti P, Wiesner L, Post FA, Haas DW, Maartens G, Sinxadi P. Determinants of early change in serum creatinine after initiation of dolutegravir-based antiretroviral therapy in South Africa. Br J Clin Pharmacol. 2024 May; 90(5):1247-1257. PMID: 38332460.
      Citations:    Fields:    Translation:HumansCells
    3. Sokhela S, Venter WDF, Bosch B, Woods J, McCann K, Akpomiemie G, Chandiwana N, Mashabane N, Tembo A, Simmons B, Lalla-Edward S, Siedner MJ, Sinxadi P, Hermans L, Fairlie L, Vos A, Abrams E, Manne-Goehler JM, Moorhouse M, Clayden P, Norris S, Qavi A, Chersich M, Masenya M, Arulappan N, Hill A. Final 192-Week Efficacy and Safety Results of the ADVANCE Trial, Comparing 3 First-line Antiretroviral Regimens. Open Forum Infect Dis. 2024 Mar; 11(3):ofae007. PMID: 38529213; PMCID: PMC10962246.
      Citations: 1     
    4. Tovar Sanchez T, Mpoudi-Etame M, Kouanfack C, Delaporte E, Calmy A, Venter F, Sokhela S, Bosch B, Akpomiemie G, Tembo A, Pepperrell T, Simmons B, Casas CP, McCann K, Mirchandani M, Hill A. Risks of metabolic syndrome in the ADVANCE and NAMSAL trials. Front Reprod Health. 2023; 5:1133556. PMID: 37791109; PMCID: PMC10544962.
      Citations: 1     
    5. Bosch B, Akpomiemie G, Chandiwana N, Sokhela S, Hill A, McCann K, Qavi A, Mirchandani M, Venter WDF. Weight and Metabolic Changes After Switching From Tenofovir Alafenamide/Emtricitabine (FTC)+Dolutegravir (DTG), Tenofovir Disoproxil Fumarate (TDF)/FTC + DTG, and TDF/FTC/Efavirenz to TDF/Lamivudine/DTG. Clin Infect Dis. 2023 04 17; 76(8):1492-1495. PMID: 36519389.
      Citations: 13     Fields:    Translation:Humans
    6. Sokhela S, Bosch B, Hill A, Simmons B, Woods J, Johnstone H, Madhi S, Qavi A, Ellis L, Akpomiemie G, Bhaskar E, Levi J, Falconer J, Mirchandani M, Perez Casas C, Moller K, Pilkington V, Pepperrell T, Venter WDF. Comparing Prospective Incident Severe Acute Respiratory Syndrome Coronavirus 2 Infection Rates During Successive Waves of Delta and Omicron in Johannesburg, South Africa. Open Forum Infect Dis. 2022 Dec; 9(12):ofac587. PMID: 36540387; PMCID: PMC9757672.
      Citations:    
    7. Wadley A, Kamerman P, Pincus T, Evangeli M, Chinaka T, Francois Venter WD, Akpomiemie G, Moorhouse M, Parker R. Slow and Steady But Not Related to HIV Stigma: Physical Activity in South Africans Living with HIV and Chronic Pain. AIDS Behav. 2023 Jun; 27(6):1950-1961. PMID: 36436140.
      Citations:    Fields:    Translation:Humans
    8. Griesel R, Sinxadi P, Kawuma A, Joska J, Sokhela S, Akpomiemie G, Venter F, Denti P, Haas DW, Maartens G. Pharmacokinetic and pharmacogenetic associations with dolutegravir neuropsychiatric adverse events in an African population. J Antimicrob Chemother. 2022 10 28; 77(11):3110-3117. PMID: 36031789; PMCID: PMC7613765.
      Citations:    Fields:    Translation:Humans
    9. Sokhela S, Bosch B, Hill A, Simmons B, Woods J, Johnstone H, Akpomiemie G, Ellis L, Owen A, Casas CP, Venter WDF. Randomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infection. J Antimicrob Chemother. 2022 09 30; 77(10):2706-2712. PMID: 35953881; PMCID: PMC9384711.
      Citations: 3     Fields:    Translation:HumansCells
    10. Mokgethi NO, Christofides N, Machisa M, Akpomiemie G, Lalla-Edward S. Quality of life and associated factors among people receiving second-line anti-retroviral therapy in Johannesburg, South Africa. BMC Infect Dis. 2022 May 12; 22(1):456. PMID: 35550020; PMCID: PMC9103409.
      Citations: 3     Fields:    Translation:HumansCells
    11. Griesel R, Maartens G, Chirehwa M, Sokhela S, Akpomiemie G, Moorhouse M, Venter F, Sinxadi P. Corrigendum to: CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz. Clin Infect Dis. 2022 Mar 01; 74(4):755. PMID: 35099526; PMCID: PMC8886893.
      Citations:    Fields:    
    12. Griesel R, Kawuma AN, Wasmann R, Sokhela S, Akpomiemie G, Venter WDF, Wiesner L, Denti P, Sinxadi P, Maartens G. Concentration-response relationships of dolutegravir and efavirenz with weight change after starting antiretroviral therapy. Br J Clin Pharmacol. 2022 03; 88(3):883-893. PMID: 34954840; PMCID: PMC7612404.
      Citations: 7     Fields:    Translation:Humans
    13. Jamieson L, Serenata C, Makhubele L, Sokhela S, Mashabane N, Akpomiemie G, Johnson LF, Venter WDF, Meyer-Rath G. Cost and cost-effectiveness of dolutegravir-based antiretroviral regimens: an economic evaluation of a clinical trial. AIDS. 2021 12 15; 35(Suppl 2):S173-S182. PMID: 34848584.
      Citations: 2     Fields:    Translation:Humans
    14. Griesel R, Maartens G, Chirehwa M, Sokhela S, Akpomiemie G, Moorhouse M, Venter F, Sinxadi P. CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz. Clin Infect Dis. 2021 12 06; 73(11):e3902-e3909. PMID: 32960272; PMCID: PMC8653639.
      Citations: 26     Fields:    Translation:Humans
    15. Chandiwana NC, Chersich M, Venter WDF, Akpomiemie G, Hill A, Simmons B, Lockman S, Serenata CM, Fairlie L, Moorhouse MA. Unexpected interactions between dolutegravir and folate: randomized trial evidence from South Africa. AIDS. 2021 02 02; 35(2):205-211. PMID: 33086234; PMCID: PMC7810415.
      Citations: 7     Fields:    Translation:HumansCells
    16. Siedner MJ, Moorhouse MA, Simmons B, de Oliveira T, Lessells R, Giandhari J, Kemp SA, Chimukangara B, Akpomiemie G, Serenata CM, Venter WDF, Hill A, Gupta RK. Reduced efficacy of HIV-1 integrase inhibitors in patients with drug resistance mutations in reverse transcriptase. Nat Commun. 2020 12 01; 11(1):5922. PMID: 33262331; PMCID: PMC7708638.
      Citations: 37     Fields:    Translation:HumansCells
    17. Venter WDF, Sokhela S, Simmons B, Moorhouse M, Fairlie L, Mashabane N, Serenata C, Akpomiemie G, Masenya M, Qavi A, Chandiwana N, McCann K, Norris S, Chersich M, Maartens G, Lalla-Edward S, Vos A, Clayden P, Abrams E, Arulappan N, Hill A. Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial. Lancet HIV. 2020 10; 7(10):e666-e676. PMID: 33010240.
      Citations: 83     Fields:    Translation:HumansCellsCTClinical Trials
    18. Wadley AL, Venter WDF, Moorhouse M, Akpomiemie G, Serenata C, Hill A, Sokhela S, Mqamelo N, Kamerman PR. High individual pain variability in people living with HIV: A graphical analysis. Eur J Pain. 2021 01; 25(1):160-170. PMID: 32939898.
      Citations:    Fields:    Translation:Humans
    19. Venter WDF, Moorhouse M, Sokhela S, Fairlie L, Mashabane N, Masenya M, Serenata C, Akpomiemie G, Qavi A, Chandiwana N, Norris S, Chersich M, Clayden P, Abrams E, Arulappan N, Vos A, McCann K, Simmons B, Hill A. Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV. N Engl J Med. 2019 08 29; 381(9):803-815. PMID: 31339677.
      Citations: 266     Fields:    Translation:HumansCellsCTClinical Trials
    20. Venter WDF, Moorhouse M, Sokhela S, Serenata C, Akpomiemie G, Qavi A, Mashabane N, Arulappan N, Sim JW, Sinxadi PZ, Wiesner L, Maharaj E, Wallis C, Boyles T, Ripin D, Stacey S, Chitauri G, Hill A. Low-dose ritonavir-boosted darunavir once daily versus ritonavir-boosted lopinavir for participants with less than 50 HIV RNA copies per mL (WRHI 052): a randomised, open-label, phase 3, non-inferiority trial. Lancet HIV. 2019 07; 6(7):e428-e437. PMID: 31202690.
      Citations: 9     Fields:    Translation:HumansCellsCTClinical Trials
    21. Venter WDF, Kambugu A, Chersich MF, Becker S, Hill A, Arulappan N, Moorhouse M, Majam M, Akpomiemie G, Sokhela S, Poongulali S, Feldman C, Duncombe C, Ripin DHB, Vos A, Kumarasamy N. Efficacy and Safety of Tenofovir Disoproxil Fumarate Versus Low-Dose Stavudine Over 96 Weeks: A Multicountry Randomized, Noninferiority Trial. J Acquir Immune Defic Syndr. 2019 02 01; 80(2):224-233. PMID: 30640204; PMCID: PMC6358196.
      Citations: 10     Fields:    Translation:Humans
    22. Daniel Francois Venter W, Chersich MF, Majam M, Akpomiemie G, Arulappan N, Moorhouse M, Mashabane N, Glencross DK. CD4 cell count variability with repeat testing in South Africa: Should reporting include both absolute counts and ranges of plausible values? Int J STD AIDS. 2018 11; 29(11):1048-1056. PMID: 29749876.
      Citations: 4     Fields:    Translation:HumansCells
    23. Venter WDF, Majam M, Akpomiemie G, Arulappan N, Moorhouse M, Mashabane N, Chersich MF. Is laboratory screening prior to antiretroviral treatment useful in Johannesburg, South Africa? Baseline findings of a clinical trial. BMC Public Health. 2017 Jul 04; 17(Suppl 3):445. PMID: 28832288; PMCID: PMC5498858.
      Citations: 3     Fields:    Translation:HumansPHPublic Health
    24. Gomez GB, Eakle R, Mbogua J, Akpomiemie G, Venter WD, Rees H. Treatment And Prevention for female Sex workers in South Africa: protocol for the TAPS Demonstration Project. BMJ Open. 2016 Sep 26; 6(9):e011595. PMID: 27678533; PMCID: PMC5051507.
      Citations: 15     Fields:    
    25. Baeten JM, Reid SE, Delany-Moretlwe S, Hughes JP, Wang RS, Wilcox E, Limbada M, Akpomiemie G, Corey L, Wald A, Celum C. Clinical and virologic response to episodic acyclovir for genital ulcers among HIV-1 seronegative, herpes simplex virus type 2 seropositive African women: a randomized, placebo-controlled trial. Sex Transm Dis. 2012 Jan; 39(1):21-4. PMID: 22183840; PMCID: PMC3244838.
      Citations: 4     Fields:    Translation:HumansCells
    26. Reid SE, Dai JY, Wang J, Sichalwe BN, Akpomiemie G, Cowan FM, Delany-Moretlwe S, Baeten JM, Hughes JP, Wald A, Celum C. Pregnancy, contraceptive use, and HIV acquisition in HPTN 039: relevance for HIV prevention trials among African women. J Acquir Immune Defic Syndr. 2010 Apr; 53(5):606-13. PMID: 19838129; PMCID: PMC2845724.
      Citations: 57     Fields:    Translation:HumansCells
    27. Delany S, Mlaba N, Clayton T, Akpomiemie G, Capovilla A, Legoff J, Belec L, Stevens W, Rees H, Mayaud P. Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa. AIDS. 2009 Feb 20; 23(4):461-9. PMID: 19155993; PMCID: PMC2948532.
      Citations: 55     Fields:    Translation:HumansCells
    28. Delany S, Rosas R, Mlaba N, Clayton T, Akpomiemie G, LeGoff J, Capovilla A, Bélec L, Stevens W, Mayaud P. Comparison of cervicovaginal lavage, cervicovaginal lavage enriched with cervical swab, and vaginal tampon for the detection of HIV-1 RNA and HSV-2 DNA in genital secretions. J Acquir Immune Defic Syndr. 2008 Dec 01; 49(4):406-9. PMID: 19186353.
      Citations: 10     Fields:    Translation:HumansCells
    Akpomiemie's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (128)
    Explore
    _
    Co-Authors (14)
    Explore
    _
    Similar People (60)
    Explore
    _